Evidence map›Paper›PMID 15465867›Full record

ArticleBiophysical journal2004

Cholesterol sensitivity and lipid raft targeting of Kir2.1 channels.

Victor G Romanenko, Yun Fang, Fitzroy Byfield, Alexander J Travis, Carol A Vandenberg, George H Rothblat, Irena Levitan

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 181 citations in OpenAlex.

  1. Review
  2. Vascular mechanical forces and vascular diseases.Journal of advanced research · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Mechanosensing by Vascular Endothelium.Annual review of physiology · 2024
    Review
  8. Article
  9. Mechanosensory entities and functionality of endothelial cells.Frontiers in cell and developmental biology · 2024
    Review
  10. Review
  11. Cholesterol regulation of mechanosensitive ion channels.Frontiers in cell and developmental biology · 2024
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. PI(4,5)PAdvances in experimental medicine and biology · 2023
    Article
  17. Article
  18. From Crosstalk to Synergism: The Combined Effect of Cholesterol and PI(4,5)PAdvances in experimental medicine and biology · 2023
    Review
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Victor G RomanenkoInstitute for Medicine and Engineering, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Yun Fang
Fitzroy Byfield
Alexander J Travis
Carol A Vandenberg
George H Rothblat
Irena Levitan
University of Pennsylvania · USChildren's Hospital of Philadelphia · USCornell University · USUniversity of California, Santa Barbara · US

Funding

TISSUE CULTURE CORE LABORATORYP01HL022633 · NHLBI · MCP HAHNEMANN UNIVERSITY · PI LUND-KATZ, SISSEL · 1985 to 2013
$26.1M
Cholesterol Regulation of Endothelial K+ ChannelsR01HL073965 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LEVITAN, IRENA · 2004 to 2024
$7.3M
Cell and molecular studies in cardiovascular engineeringR01HL064388 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DAVIES, PETER FRANCIS · 2001 to 2005
$6.9M
Scavenger Receptor BI in Cellular Cholesterol MetabolismR01HL063768 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI LONDON, ERWIN · 2000 to 2008
$3.9M
ORGANIZATION AND FUNCTIONS OF LIPID RAFTS IN SPERMATOZOAR01HD045664 · NICHD · CORNELL UNIVERSITY ITHACA · PI TRAVIS, ALEXANDER J · 2004 to 2008
$1.3M
PDZ Interaction and Inward Rectifier K+ Channel FunctionR01NS043377 · NINDS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI VANDENBERG, CAROL A · 2002 to 2005
$1.1M
NHLBI NIH HHS HL073965-01A1NHLBI NIH HHS HL22633NHLBI NIH HHS HL63768NHLBI NIH HHS HL64388-01A1NHLBI NIH HHS P01 HL022633NHLBI NIH HHS R01 HL063768NHLBI NIH HHS R01 HL064388NHLBI NIH HHS R01 HL073965NICHD NIH HHS HD-045664NICHD NIH HHS R01 HD045664NINDS NIH HHS NS43377NINDS NIH HHS R01 NS043377
6 · The paper itself

Abstract

This study investigates how changes in the level of cellular cholesterol affect inwardly rectifying K+ channels belonging to a family of strong rectifiers (Kir2). In an earlier study we showed that an increase in cellular cholesterol suppresses endogenous K+ current in vascular endothelial cells, presumably due to effects on underlying Kir2.1 channels. Here we show that, indeed, cholesterol increase strongly suppressed whole-cell Kir2.1 current when the channels were expressed in a null cell line. However, cholesterol level had no effect on the unitary conductance and only little effect on the open probability of the channels. Moreover, no cholesterol effect was observed either on the total level of Kir2.1 protein or on its surface expression. We suggest, therefore, that cholesterol modulates not the total number of Kir2.1 channels in the plasma membrane but rather the transition of the channels between active and silent states. Comparing the effects of cholesterol on members of the Kir2.x family shows that Kir2.1 and Kir2.2 have similar high sensitivity to cholesterol, Kir2.3 is much less sensitive, and Kir2.4 has an intermediate sensitivity. Finally, we show that Kir2.x channels partition virtually exclusively into Triton-insoluble membrane fractions indicating that the channels are targeted into cholesterol-rich lipid rafts.

Indexed as

AnimalsCHO CellsCholesterolCricetinaeCricetulusIon Channel GatingMembrane MicrodomainsMembrane PotentialsPotassium Channels, Inwardly RectifyingCholesterolKir2.1 channelPotassium Channels, Inwardly Rectifying

Identifiers

PMID15465867
PMCPMC1304896
OpenAlexW1968786790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.